Lunit Partners with Saudi Arabia's Health Ministry for AI Imaging Solutions Deployment

Lunit's Innovative Step towards AI Healthcare in Saudi Arabia

Lunit, a prominent player in AI solutions for cancer diagnostics, has announced its latest venture with the Ministry of National Guard Health Affairs (MNGHA) in Saudi Arabia. This partnership will see the implementation of Lunit's AI-powered imaging solutions, namely Lunit INSIGHT CXR and Lunit INSIGHT MMG, aiming to streamline cancer detection processes in the region.

The deployment will occur through stc, a notable ICT subsidiary of Saudi Arabia's stc Group, which will act as the systems integrator for this pivotal healthcare project. The integration of Lunit’s solutions into MNGHA's existing Picture Archiving and Communication System (PACS) marks a significant development in the digital transformation of healthcare within the Kingdom. Healthcare professionals will now have seamless access to AI-generated analysis outcomes, enhancing their decision-making capabilities.

MNGHA, established in 1982, is a key government healthcare system that offers services to National Guard personnel and their families, as well as the general public. With a wide-ranging network of hospitals and medical centers across major cities like Riyadh and Jeddah, MNGHA has developed a commendable digital healthcare infrastructure. Notably, King Abdulaziz Medical City in Riyadh became the world’s first healthcare institution to reach the highest level of HIMSS digital maturity assessment across four models in 2022, exemplifying its commitment to health digitization.

This agreement with MNGHA exemplifies Lunit’s expanding footprint in the Saudi healthcare landscape. The company had earlier taken part in initiatives linked with the SEHA Virtual Hospital and the Healthcare Sandbox program, contributing to Saudi Arabia’s Vision 2030 roadmap, which emphasizes the digital reform of healthcare services. Additionally, in 2023, Lunit secured a collaboration to supply its imaging solutions to Dr. Sulaiman Al Habib Medical Group, further showcasing its relevance in the region.

Brandon Suh, CEO of Lunit, highlighted the significance of this collaboration, stating, “MNGHA has one of the most advanced digital healthcare infrastructures, and this deployment reflects the capabilities of our AI solutions and their ability to leverage large-scale healthcare systems.” He emphasized the goal of strengthening Lunit's presence in Saudi Arabia and facilitating wider access to AI-driven cancer screening across the Middle East.

Founded in 2013, Lunit aims to revolutionize cancer treatment with its suite of clinically validated solutions, ranging from medical imaging to biomarker analysis. Their pioneering offerings support early cancer detection and more informed treatment choices, forming a crucial part of the cancer care continuum. Lunit’s products, including the FDA-cleared Lunit INSIGHT Breast Suite, are currently utilized in over 10,000 sites across more than 65 countries around the world. The company combines deep medical expertise with continuously updated datasets to provide substantial impacts for patients and healthcare professionals.

As Lunit embarks on this important partnership with MNGHA, it not only brings state-of-the-art technology to the forefront of healthcare in Saudi Arabia but also paves the way for future innovations in the battle against cancer in the region. Through their collaboration with solutions by stc, Lunit aims to redefine cancer diagnosis and treatment efficiency, ultimately contributing to better healthcare outcomes for all.

To learn more about Lunit's healthcare advancements and solutions, visit lunit.io.